Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $1000.0.

  • Arcadia Biosciences' Cash from Financing Activities fell 7500.0% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6000.0, marking a year-over-year decrease of 3333.33%. This contributed to the annual value of $9000.0 for FY2024, which is 9983.67% down from last year.
  • Arcadia Biosciences' Cash from Financing Activities amounted to $1000.0 in Q3 2025, which was down 7500.0% from $5000.0 recorded in Q1 2025.
  • Over the past 5 years, Arcadia Biosciences' Cash from Financing Activities peaked at $22.0 million during Q1 2021, and registered a low of -$114000.0 during Q4 2021.
  • Its 5-year average for Cash from Financing Activities is $2.7 million, with a median of $5000.0 in 2024.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 10147.36% in 2021, then surged by 13752500.0% in 2023.
  • Arcadia Biosciences' Cash from Financing Activities (Quarter) stood at -$114000.0 in 2021, then soared by 4060.53% to $4.5 million in 2022, then crashed by 99.84% to $7000.0 in 2023, then plummeted by 42.86% to $4000.0 in 2024, then crashed by 75.0% to $1000.0 in 2025.
  • Its Cash from Financing Activities was $1000.0 in Q3 2025, compared to $5000.0 in Q1 2025 and $4000.0 in Q3 2024.